Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by jdsd0517on Dec 22, 2022 12:33pm
115 Views
Post# 35187370

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NoShort - The Bottomless fool, The Tree Planter....

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NoShort - The Bottomless fool, The Tree Planter....Oh boy, there is so much wrong in your post it's hard to know where to begin.  I will start with the basics and will not resort to name calling.  And since i know you don't believe anything I say (your oft used ad hominem attack of calling me a liar), I am going to point you to other sources

- the value of any firm (or company) is the discounted value of its ability to create free cash flow.  This isn't my definition, it is the classic corporate finance definition. (this book if you want a deep dive: https://www.wiley.com/en-us/Valuation%3A+Measuring+and+Managing+the+Value+of+Companies%2C+7th+Edition-p-9781119610885)

- the value of the firm is independent of how it is financed, other than issues related to bankruptcy risk (see Miller & Modigliani, as well as Altman).

- Quote: "The value of a firm is basically the sum of claims of its creditors and shareholders. Therefore, one of the simplest ways to measure it is by adding the market value of its debt, equity, and minority interest. Cash and cash equivalents would then be deducted to arrive at the net value." (https://efinancemanagement.com/investment-decisions/value-of-a-firm)
 
- based on the above, in coming up with the value based on cash flows (enterprise value), we then need to adjust for capital structure.  If you are using an EBITDA multiple, you end up with enterprise value. 

- Note that the concept of an EBITDA/market multiple is nonsensical since the numerator is equity only, but the denominator excludes debt service costs)

- As a result of the above, your calculation of equity value is incorrect because you are applying an EV/EBITDA multple and then ignoring capital structure.

- after using your estimates and multiples, you end up with a stock value of $1.75

Next question?  Or attack?


Noshortsallowed wrote: The whole point of attributing a multiple to a cash flow analysis contemplates debt. The idea is that you can't assess EPA (most often because of things like debt) so you attribute a multiple to its cash flow/Ebitda.  Yet you discount the debt as well to its CURRENT cash flows and attribute NOTHING to its growth prospects.  You are so misleading with your analysis that it amounts to lies.


<< Previous
Bullboard Posts
Next >>